Počet záznamů: 1  

Differentiation of mesenchymal stem cells on fibrin assemblies supported by immobilized growth factors FGF2 and VEGF

  1. 1.
    SYSNO ASEP0567459
    Druh ASEPC - Konferenční příspěvek (mezinárodní konf.)
    Zařazení RIVD - Článek ve sborníku
    NázevDifferentiation of mesenchymal stem cells on fibrin assemblies supported by immobilized growth factors FGF2 and VEGF
    Tvůrce(i) Musílková, Jana (FGU-C) RID, ORCID
    Filová, Elena (FGU-C) RID, ORCID
    Kaplan, Ondřej (FGU-C) RID
    Bačáková, Lucie (FGU-C) RID, ORCID
    Zdroj.dok.NANOCON 2021 - Conference proceedings. - Ostrava : Tanger Ltd., 2021 - ISSN 2694-930X - ISBN 978-80-88365-00-6
    Rozsah strans. 323-328
    Poč.str.6 s.
    Forma vydáníOnline - E
    AkceInternational Conference on Nanomaterials - Research & Application /13./ NANOCON
    Datum konání20.10.2021 - 22.10.2021
    Místo konáníBrno
    ZeměCZ - Česká republika
    Typ akceWRD
    Jazyk dok.eng - angličtina
    Země vyd.CZ - Česká republika
    Klíč. slovastem cells ; differentiation ; growth factors ; smooth muscle cells ; fibrin assemblies
    Obor OECDBiomaterials (as related to medical implants, devices, sensors)
    CEPNU20-08-00208 GA MZd - Ministerstvo zdravotnictví
    Institucionální podporaFGU-C - RVO:67985823
    EID SCOPUS85127256349
    DOI10.37904/nanocon.2021.4360
    AnotaceBioartificial heart valves and vascular grafts prepared from decellularized tissues could be recellularized with bone marrow-derived mesenchymal stem cells (MSCs) that are able to differentiate into both smooth muscle cells and endothelial cells. MSCs differentiation is facilitated by sustained release of growth factors. In our study assemblies based on fibrin, fibrin with heparin, fibrin with adsorbed or covalently-immobilized vascular endothelial growth factor A165 (VEGF) or basic fibroblast growth factor (FGF-2) via binding to heparin attached to fibrin have been prepared and were evaluated for their stimulation of MSCs differentiation. We estimated the mRNA expression of endothelial marker CD31 (PECAM1), smooth muscle marker α-actin (ACTA2), osteoblast markers osteocalcin (BGLAP) and alkaline phosphatase (ALP). The gene expression was estimated using RT-PCR on days 1, 7 and 21 after seeding. The cell morphology and viability was evaluated by LIVE/DEAD staining. VEGF, both adsorbed and covalently bound, increased significantly the expression of smooth muscle marker α-actin. The mRNA expression of ACTA2 on day 7 and 21 raised more than 200 times in comparison to control samples (undifferentiated cells before seeding). The ACTA2 gene expression significantly exceeded the expression of all other evaluated genes at all time intervals. Moreover, on day 21, the late smooth muscle marker desmin (DES) was steeply rising in cells cultivated on assemblies containing heparin and covalently bound VEGF. The expression of osteocalcin was minimal. We conclude that fibrin assembly containing covalently bound VEGF is the most convenient for MSCs differentiation towards smooth muscle cells.
    PracovištěFyziologický ústav
    KontaktLucie Trajhanová, lucie.trajhanova@fgu.cas.cz, Tel.: 241 062 400
    Rok sběru2023
    Elektronická adresahttps://www.confer.cz/nanocon/2021/read/4360-differentiation-of-mesenchymal-stem-cells-on-fibrin-assemblies-supported-by-immobilized-growth-factors-fgf2-and-vegf.pdf
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.